» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics (PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

JILIN PROVINCE HUINAN

WVB Number : HKG000030678 Country : People's Republic of China
SIC categorization : MEDICINAL CHEMS,BOTANICL PDS (2833) ISIN : CNE100000130
FT categorization : DRUGS (433)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Company is principally engaged in the manufacture and distribution of biochemical medicines in the PRC under the brand names of Changlong and Shendi. Main products cover, inter alia antibiotics and medicines for the treatment of cerebral embolism, brain and heart blood vessels related diseases, hepatitis, diabetes, prostatic diseases, pain and bleeding caused by cancer and surgery, hormone disorder, inflammation of gallbladder gallstones.
Phone : 86 0435 821 2688 Fax : 0435 821 2738
Chairman: : HONG ZHANG Auditor : REANDA LAU & AU YEUNG
CEO/Managing Director : N/A

» Company Facts

Net Profit Margin (%) 17.89  
Operating Margin (%) 21.66  
Return on Assets (%) 10.03  
Return on Equity (%) 13.11  
Employees 406  

» Company Financials

  Annual (2010)
Income Statement
('000 CNY )
Sales/Total Revenue 200,630  
EBITDA 56,074  
EBIT 40,470  
Net Income 35,891  
Balance Sheet
( '000 CNY)
Total Current Assets 251,421  
Total Assets 379,672  
Current Liabilities 81,048  
Total Liabilities & Debt 88,058  
Total Equity 291,614  
Cash & Flow
( '000 CNY)
Net Income/Staring Line 43,282  
Cash from Operating 73,148  
Cash from Investing -3,105  
Cash from Financing 2,020  
Cash & Equivalent Yr End 99,559